Related Experiment Video

Updated: May 13, 2026

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection
08:14

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection

Published on: October 6, 2015

A mathematical model for HIV and hepatitis C co-infection and its assessment from a statistical perspective

Amparo Yovanna Castro Sanchez1, Marc Aerts, Ziv Shkedy

  • 1Interuniversity Institute for Biostatistics and statistical Bioinformatics, Hasselt University, Agoralaan 1, B3590 Diepenbeek, Belgium. amparo.castrosanchez@uhasselt.be

Epidemics
|February 27, 2013
PubMed

Insights

A new mathematical model quantifies the impact of co-infection with the hepatitis C virus (HCV) and human immunodeficiency virus (HIV) in injecting drug users (IDUs). The model highlights the critical role of syringe sharing and transmission rates in disease progression.

Area of Science:

  • Epidemiology
  • Mathematical Modeling
  • Public Health

Background:

  • Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) pose significant public health risks, particularly among injecting drug users (IDUs).
  • HIV and HCV co-infection accelerates liver disease progression, increasing risks for cirrhosis and liver cancer.

Purpose of the Study:

  • To develop and statistically assess a novel joint mathematical model for quantifying HIV and HCV co-infection dynamics in IDUs.
  • To identify key parameters influencing co-infection transmission and progression within this population.

Main Methods:

  • A joint mathematical model was developed to simulate HIV and HCV co-infection in IDUs.
  • Statistical methods were employed for model assessment, including component selection, parameter estimation, sensitivity analysis, and pattern identification.
  • Longitudinal data from a heroin user study in Italy was utilized for model application and validation.

Main Results:

  • The model successfully quantifies the impact of HIV and HCV co-infection in IDUs.
  • Statistical assessment identified crucial model components and parameter values.
  • Contact rates (syringe sharing) and transmission rates per event were found to be highly influential parameters.

Conclusions:

  • The proposed joint mathematical model provides valuable insights into HIV and HCV co-infection dynamics.
  • Understanding transmission parameters is vital for public health interventions targeting IDUs.
  • The model serves as a tool for further research and prevention strategies.

More Related Videos

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis10:12

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis

Published on: September 11, 2019

An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells07:39

An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells

Published on: August 15, 2012

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...